Organic Letters
Letter
2000, 122, 6797−6798. (c) Jurkauskas, V.; Sadighi, J. P.; Buchwald, S.
L. Org. Lett. 2003, 5, 2417−2420.
induction observed in the reductions of 7, 11, and 13 is
intriguing and deserving of further investigation.
(6) (a) Lipshutz, B. H.; Servesko, J. M.; Petersen, T. B.; Papa, P. P.;
Lover, A. A. Org. Lett. 2004, 6, 1273−1275. (b) Lipshutz, B. H.;
Tanaka, N.; Taft, B. R.; Lee, C.-T. Org. Lett. 2006, 8, 1963−1966.
(c) Lipshutz, B. H. Synlett 2009, 2009, 509−524.
In summary, we have developed a novel method to
desymmetrize γ,γ-disubstituted cyclohexadienones to chiral
cyclohexenones utilizing the Cu(I)-9 complex and DIBAL−
HMPA as the reductant. The method exerts effective
stereocontrol even in the challenging differentiation between
a methyl (CH3) and methylene (CH2CH2R) group and enables
the asymmetric formal synthesis of the natural enantiomer of
retigeranic acid. Additionally, when faced with an unexpectedly
low ee in the reduction of dichloromethane-substituted
substrate 15, we demonstrated the applicability of oxazaboro-
lidinium-catalyzed [4 + 2]-cycloadditions for the purpose of
desymmetrizing cyclohexadienones. The Diels−Alder adduct
thus obtained could be further exploited to stereoselectively
obtain chiral 3,4,4-trisubstituted cyclohex-2-en-1-ones.
(7) See Supporting Information for details.
(8) (a) Larionov, O. V.; Corey, E. J. Org. Lett. 2010, 12, 300−302.
(b) Corey, E. J.; Huang, A. X. J. Am. Chem. Soc. 1999, 121, 710−714.
(c) Tsuda, T.; Hayashi, T.; Satomi, H.; Kawamoto, T.; Saegusa, T. J.
Org. Chem. 1986, 51, 537−540.
(9) Typical experimental procedure: To a flask containing CuI (8.0 mg,
42 μmol) and (R,R)-Ph-BPE (23 mg, 42 μmol) under an atmosphere
of argon was added degassed THF (3.0 mL), and the suspension was
sonicated for 20 min to obtain a clear solution. Then, HMPA (0.44
mL, 2.5 mmol) was added and the solution was cooled to −78 °C
before DIBAL (1 M in DCM, 0.84 mL, 0.84 mmol) was added. After
10 min, dienone 7 (80 mg, 0.42 mmol) was added and the reaction
was warmed to −50 °C. When the substrate was fully converted as
judged by TLC, saturated aqueous NH4Cl (5 mL) and saturated
aqueous Rochelle salt (5 mL) were added. The aqueous phase was
extracted with CH2Cl2 (3 × 10 mL), and the combined organic phases
were washed with brine (5 mL), dried over Na2SO4, filtered, and
concentrated in vacuo. Purification by column chromatography (SiO2,
hexanes/ethyl acetate 50:1) afforded the enone (+)-3 (68 mg, 85%
yield, 80% ee) as a colorless oil.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
Crystallographic data for compound 24 (CIF)
Experimental procedures and characterization data for all
reactions and products (PDF)
(10) Paquette, L. A.; Heidelbaugh, T. M. Synthesis 1998, 1998, 495−
508.
(11) Notably, the procedure described herein affords higher
enantioselectivity in the reaction 11→12 compared to a recently
reported rhodium-catalyzed conjugate reduction; see: Naganawa, Y.;
Kawagishi, M.; Ito, J.-I.; Nishiyama, H. Angew. Chem., Int. Ed. 2016, 55,
6873−6876.
(12) (a) Auwers, K.; Winternitz, F.; Jacobson, P. Ber. Dtsch. Chem.
Ges. 1902, 35, 465−471. (b) Auwers, K.; Keil, G. Ber. Dtsch. Chem. Ges.
1902, 35, 4207−4217. (c) Wenkert, A.; Haviv, F.; Zeitlin, A. J. Am.
Chem. Soc. 1969, 91, 2299−2307.
1
Copies of H and 13C NMR spectra, chiral HPLC and
X-ray crystallographic data for compound 24 (PDF)
AUTHOR INFORMATION
■
Corresponding Author
ORCID
(13) Treatment of 15 with DIBAL (2 equiv) and HMPA (6 equiv) in
THF at −50 °C afforded unreacted starting material after 14 h.
(14) (a) Corey, E. J. Angew. Chem., Int. Ed. 2009, 48, 2100−2117.
(b) Corey, E. J. Angew. Chem., Int. Ed. 2002, 41, 1650−1667.
(c) Reddy, K. M.; Bhimireddy, E.; Thirupathi, B.; Breitler, S.; Yu, S.;
Corey, E. J. J. Am. Chem. Soc. 2016, 138, 2443−2453. (d) Thirupathi,
B.; Breitler, S.; Reddy, K. M.; Corey, E. J. J. Am. Chem. Soc. 2016, 138,
10842−10845.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We are grateful to Pfizer Inc. for a research grant. Y.H.
acknowledges support from Prof. Zhen Yang and Prof. Jiahua
Chen of Peking University. S.B. acknowledges a postdoctoral
fellowship from the Swiss National Science Foundation.
(15) For a similar, organocatalyzed reaction, see: Takagi, R.; Nishi, T.
Org. Biomol. Chem. 2015, 13, 11039−11045.
(16) Liu, D.; Canales, E.; Corey, E. J. J. Am. Chem. Soc. 2007, 129,
1498−1499.
(17) The product was obtained as a single diastereomer with
1
complete endo-selectivity, as judged by H NMR and NOE studies.
REFERENCES
■
(18) This approach affords the product with cis-relationship between
the larger CHCl2-group and the incoming nucleophile as determined
by NOE studies. This is complementary to the anti-addition product
obtained from conjugate addition to dienone 15; see: ref 12c).
(19) The relative stereochemistry of these products was independ-
ently established by NOE.
(1) Corey, E. J.; Desai, M. C.; Engler, T. A. J. Am. Chem. Soc. 1985,
107, 4339−4341.
(2) Because of its intriguing structure retigeranic acid (1) has been a
synthetic target of several research groups. For subsequent successful
syntheses, see: (a) Wright, J.; Drtina, G. J.; Roberts, R. A.; Paquette, L.
A. J. Am. Chem. Soc. 1988, 110, 5806−5817. (b) Singh, S. K.; Wender,
P. A. Tetrahedron Lett. 1986, 51, 2047−2050. (c) Hudlicky, T.;
Fleming, A.; Radesca, L. J. Am. Chem. Soc. 1989, 111, 6691−6707.
(d) Adams, D. R.; Hudlicky, T. In Total Synthesis of Natural Products;
Li, J. J., Corey, E. J., Eds.; Springer-Verlag: 2012; pp 235−258.
(3) Snider, B. B.; Rodini, D. J.; van Straten, J. J. Am. Chem. Soc. 1980,
102, 5872−5880.
(4) For an overview of desymmetrization methods of cyclo-
hexadienones, see: Kalstabakken, K. A.; Harned, A. M. Tetrahedron
2014, 70, 9571−9585.
(5) (a) Appella, D. H.; Moritani, Y.; Shintani, R.; Ferreira, E. M.;
Buchwald, S. L. J. Am. Chem. Soc. 1999, 121, 9473−9474. (b) Moritani,
Y.; Appella, D. H.; Jurkauskas, V.; Buchwald, S. L. J. Am. Chem. Soc.
D
Org. Lett. XXXX, XXX, XXX−XXX